These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24854748)

  • 1. [Systematic review of primary stenting for arteriosclerotic occlusion in below-the-knee arteries].
    Yang X; Lu X; Ye K; Qin J; Huang L; Peng Z; Yuan F; Jiang M
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(11):821-7. PubMed ID: 24854748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease.
    Yang X; Lu X; Ye K; Li X; Qin J; Jiang M
    Vasc Endovascular Surg; 2014 Jan; 48(1):18-26. PubMed ID: 24212407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
    Kudo T; Chandra FA; Ahn SS
    J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
    J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents.
    Antoniou GA; Chalmers N; Kanesalingham K; Antoniou SA; Schiro A; Serracino-Inglott F; Smyth JV; Murray D
    J Endovasc Ther; 2013 Apr; 20(2):131-44. PubMed ID: 23581752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sense and nonsense of bare metal stents below the knee.
    Caradu C; Brizzi V; Auque H; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2016 Oct; 57(5):653-66. PubMed ID: 27177357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: a meta-analysis of randomized trials.
    Wu R; Yao C; Wang S; Xu X; Wang M; Li Z; Wang S
    J Vasc Surg; 2014 Jun; 59(6):1711-20. PubMed ID: 24836770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.
    Spreen MI; Martens JM; Hansen BE; Knippenberg B; Verhey E; van Dijk LC; de Vries JP; Vos JA; de Borst GJ; Vonken EJ; Wever JJ; Statius van Eps RG; Mali WP; van Overhagen H
    Circ Cardiovasc Interv; 2016 Feb; 9(2):e002376. PubMed ID: 26861113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparation of drug-eluting stents and control therapy for the treatment of infrapopliteal artery disease: a Bayesian analysis.
    Li Y; Shen X; Zhuang H
    Int J Surg; 2023 Dec; 109(12):4286-4297. PubMed ID: 37720942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial.
    Wakkie T; Konijn LCD; van Herpen NPC; Maessen MFH; Spreen MI; Wever JJ; Statius van Eps RG; Veger HT; van Dijk LC; Mali WPTM; van Overhagen H
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):376-381. PubMed ID: 31807849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of drug-eluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favorable mid-term patency and limb salvage results.
    Lookstein R; Ward T; Kim E; Fischman A; Nowakowksi F; Ellozy S; Teodorescu V; Vouyouka A; Faries P; Weintraub J
    J Cardiovasc Surg (Torino); 2011 Aug; 52(4):461-6. PubMed ID: 21792153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (Part 2: Below the knee).
    Jens S; Conijn AP; Koelemay MJ; Bipat S; Reekers JA
    Eur J Vasc Endovasc Surg; 2014 May; 47(5):536-44. PubMed ID: 24650395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancements to angioplasty for peripheral arterial occlusive disease: systematic review, cost-effectiveness assessment and expected value of information analysis.
    Simpson EL; Kearns B; Stevenson MD; Cantrell AJ; Littlewood C; Michaels JA
    Health Technol Assess; 2014 Feb; 18(10):1-252. PubMed ID: 24524731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease.
    Katsanos K; Spiliopoulos S; Diamantopoulos A; Siablis D; Karnabatidis D; Scheinert D
    JACC Cardiovasc Interv; 2016 Feb; 9(3):259-267. PubMed ID: 26777329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
    Pietzsch JB; Geisler BP; Garner AM; Zeller T; Jaff MR
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):546-54. PubMed ID: 24782424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.
    Rastan A; Tepe G; Krankenberg H; Zahorsky R; Beschorner U; Noory E; Sixt S; Schwarz T; Brechtel K; Böhme C; Neumann FJ; Zeller T
    Eur Heart J; 2011 Sep; 32(18):2274-81. PubMed ID: 21622669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.